Pfizer Earnings & Forecasts

Pfizer (PFE) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Montant surprise des bénéfices trimestriels

Trimestre Fiscal	Date de Déclaration	BPA Réel	BPA Estimé	Surprendre %
Q2	Aug 4, 2026	$0.77	$0.68	13.2 %
Q1	May 5, 2026	$0.75	$0.72	4.17 %
Q4	Feb 3, 2026	$0.66	$0.56	17.9 %
Q3	Nov 4, 2025	$0.87	$0.65	33.9 %

Quarterly Revenue (Billions)

Montant surprise des revenus trimestriels

Trimestre Fiscal	Date de Déclaration	Revenu Réel	Revenu Estimé	Surprendre %
Q2	Aug 4, 2026	$15.03B	$14.43B	4.22 %
Q1	May 5, 2026	$14.45B	$13.81B	4.68 %
Q4	Feb 3, 2026	$17.56B	$16.87B	4.08 %
Q3	Nov 4, 2025	$16.65B	$16.55B	0.61 %

Pfizer Guidance

Pfizer (PFE) a publié ses dernières prévisions le août 4, 2026 pour fiscal year 2026. La société a prévu un BPA compris entre $2.8 - $3 et $2.97, contre un consensus de Pfizer. $60.5B - $62.5B a également prévu un chiffre d'affaires compris entre Pfizer et PFE pour la période.

Par rapport aux prévisions précédentes, $59.5B - $62.5B Pfizer ses perspectives de BPA ont été revues à la baisse, passant d'une fourchette précédente de maintenu à $2.8 - $3. Du côté du chiffre d'affaires, la société a revu à la baisse ses prévisions de chiffre d'affaires, passant d'une fourchette précédente de Pfizer à maintenu.

undefined a publié undefined mises à jour de ses recommandations entre undefined et undefined. undefined

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.68	$0.72	$0.56	$0.65
Actual	$0.77	$0.75	$0.66	$0.87
Surprise	+13.2%	+4.17%	+17.9%	+33.9%
Revenue
Estimate	$14.43B	$13.81B	$16.87B	$16.55B
Actual	$15.03B	$14.45B	$17.56B	$16.65B
Surprise	+4.22%	+4.68%	+4.08%	+0.61%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.73	$0.71	$0.85	$0.70
Revenue
Consensus	$15.96B	$16.93B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on potential deal to reopen Strait of Hormuz.

Avi Kapoor

Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss

Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.

Vandana Singh

Stock Market Today: S&P 500, Dow and Nasdaq Futures Gain as Scott Bessent Says Hormuz Deal Could Come Soon— Caterpiller, Palantir in Focus (UPDATED)

U.S. stock futures edged higher on Tuesday, with Dow, S&P 500 and Nasdaq 100 futures advancing after Wall Street's broad rally on Monday.

Eva Mathew

PRO
Pfizer Q2 Adj. EPS $0.77 Beats $0.69 Estimate, Sales $15.034B Beat $14.412B Estimate

Pfizer (NYSE:PFE) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59 percent. This is a 1.28 percent decrease over earnings of $0.78 per share from the same period

Benzinga Newsdesk

PRO
Pfizer Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.95 Est; Raises FY2026 Sales Guidance from $59.500B-$62.500B to $60.500B-$62.500B vs $61.793B Est

Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.95 analyst estimate. Raises FY2026 sales outlook from $59.500 billion-$62.500 billion to $60.500 billion-$62.500 billion vs $61.793

Benzinga Newsdesk

Dow Closes at Record High, Nasdaq Surges 2%, but Fear & Greed Index Signals Investors Are Still Playing It Safe

Fear & Greed Index improves, Dow Jones hits record high, oil prices fall after Trump's Iran decision. CNH & Makemytrip stocks gain on earnings.

Avi Kapoor

Pfizer Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL